Risk of Systemic Comorbidities in Patients With Inherited Retinal Diseases

Ophthalmic Surg Lasers Imaging Retina. 2026 Aug 25:1-7. doi: 10.3928/23258160-20260722-02. Online ahead of print.ABSTRACTBACKGROUND AND OBJECTIVE: There is limited evidence of the rates at which inherited retinal disease (IRD) patients experience systemic conditions. This study aimed to evaluate the

M Matthew L Regueiro

Cardiovascular-Related Mortality and Hospitalizations in Patients with Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis: A Post Hoc Analysis of the Phase 3 ATTR-ACT and Long-Term Extension

Cardiol Ther. 2026 Aug 27. doi: 10.1007/s40119-026-00470-8. Online ahead of print.ABSTRACTINTRODUCTION: Patients with transthyretin amyloid cardiomyopathy (ATTR-CM) are at high risk of cardiovascular (CV)-related hospitalizations (CVH), which are associated with higher mortality. In the phase 3 stud

T Thibaud Damy

From liver to cardiovascular system: the MASLD-ASCVD continuum

Intern Emerg Med. 2026 Aug 27. doi: 10.1007/s11739-026-04497-6. Online ahead of print.ABSTRACTMetabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide and is increasingly recognized as a systemic cardiometabolic disorder. Atherosclerotic

A Andrea Boccatonda

Supratherapeutic Digoxin Levels in Children with Cardiac Disease

Pediatr Cardiol. 2026 Aug 27. doi: 10.1007/s00246-026-04442-6. Online ahead of print.ABSTRACTWe characterized our institution's experience with supratherapeutic digoxin levels (> 2.0 mcg/L) which is reported to occur in 0.8-4% of treated patients. Children < 18 years with a measured digoxin level be

V Valerie Bailey